Literature DB >> 9711836

Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa.

N Gotoh1, H Tsujimoto, A Nomura, K Okamoto, M Tsuda, T Nishino.   

Abstract

For characterization of the MexCD-OprJ efflux system of Pseudomonas aeruginosa involved in resistance to fluoroquinolones and the fourth-generation cephems, we constructed mexC, mexD or oprJ mutants from the nfxB-type PAO strains by insertion mutagenesis. The gene products in the resultant mutants were examined by immunoblot assay using murine and rabbit antibodies developed against purified protein and synthetic oligopeptides. Susceptibility of the mexC (MexC- MexD- OprJ-) and mexD (MexC+ MexD- OprJ-) mutants to fluoroquinolone and the fourth-generation cephems was comparable to that of the wild-type strain PAO1. However, the oprJ mutant (MexC+ MexD+ OprJ-) was still less susceptible than PAO1, since a MexCD-OprM chimera system, which generated from a functional assist of the constitutively expressed OprM, can function in the efflux of the antimicrobial agents in the oprJ mutant. In fact, transformation of the oprJ mutant with an OprM-expression plasmid decreased the former's susceptibility to the levels exhibited by the nfxB mutant without affecting the substrate specificity of MexCD-OprJ.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711836     DOI: 10.1111/j.1574-6968.1998.tb13122.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  22 in total

1.  Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa.

Authors:  L Pumbwe; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa.

Authors:  Kiyomi Okamoto; Naomasa Gotoh; Takeshi Nishino
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  H Maseda; H Yoneyama; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.

Authors:  Elena B Tikhonova; Quiju Wang; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

8.  Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli.

Authors:  Lars Hestbjerg Hansen; Elsebetta Johannesen; Mette Burmølle; Anders Hay Sørensen; Søren J Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.

Authors:  N Gotoh; H Tsujimoto; M Tsuda; K Okamoto; A Nomura; T Wada; M Nakahashi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.